Lexington, MA, United States of America

Hyon K Choi

This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyon K Choi. Retrieved from https://idiyas.com/inventor/hyon-k-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyon K Choi: Innovator in Treatments for Immune-Mediated Ear Disorders

Introduction

Hyon K Choi is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of immune-mediated ear disorders. His innovative approach has led to the development of effective therapeutic methods that address these complex conditions.

Latest Patents

Hyon K Choi holds 1 patent for his work titled "Treatments for immune-mediated ear disorders." This patent discloses methods for treating immune-mediated ear disorders, such as immune-mediated chronic vestibular disorders (IMCVDs), through the administration of a therapeutically-effective amount of a TNF antagonist, such as etanercept or infliximab. Additionally, it includes the use of a pyrimidine synthesis inhibitor, such as leflunomide, to alleviate symptoms associated with these disorders.

Career Highlights

Choi is affiliated with The General Hospital Corporation, where he continues to advance his research and clinical applications. His work has garnered attention for its potential to improve the quality of life for individuals suffering from immune-mediated conditions.

Collaborations

Some of his notable coworkers include Mahboob U Rahman and Dennis S Poe, who have collaborated with him on various projects within the medical field.

Conclusion

Hyon K Choi's innovative contributions to the treatment of immune-mediated ear disorders highlight his dedication to advancing medical science. His work not only reflects his expertise but also his commitment to improving patient outcomes through effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…